HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158].

Abstract
The aim of this study is to determine whether or not CCKB receptor antagonist PD135158 suppresses conditioned fear. Rats were individually subjected to 30 min of inescapable electric footshock in a chamber with a grid floor. PD135158 or the vehicle was administered 30 min before placing the rats in the shock chamber again. The rats were observed for 5 min without receiving shock. The administration of PD135158 30 min before conditioned-fear stress significantly reduced freezing behavior. PD135158 blocked the expression of conditioned fear. PD135158 was again administered 30 min before footshock. Then, the rats were individually subjected to 30 min of inescapable electric footshock in the shock chamber. Twenty-four hours after receiving footshock, the rats were again placed in the shock chamber and observed for 5 min without shock administration. The administration of PD135158 30 min before footshock significantly reduced conditioned freezing. PD135158 blocked the anxiety of conditioned fear. PD135158 blocked not only the anxiety, but also the expression of conditioned fear. These results suggest that CCKB receptor might play an important role in conditioned-fear stress. They indicate that CCKB receptor is related to anxiety.
AuthorsT Tsutsumi, K Isogawa, Y Kouno, T Hikichi, H Nagayama, J Akiyoshi
JournalNihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology (Nihon Shinkei Seishin Yakurigaku Zasshi) Vol. 18 Issue 1 Pg. 15-8 (Feb 1998) ISSN: 1340-2544 [Print] Japan
PMID9592807 (Publication Type: Journal Article)
Chemical References
  • Anti-Anxiety Agents
  • Indoles
  • Receptor, Cholecystokinin B
  • Receptors, Cholecystokinin
  • PD 135158
  • Meglumine
Topics
  • Animals
  • Anti-Anxiety Agents (pharmacology, therapeutic use)
  • Conditioning, Psychological
  • Disease Models, Animal
  • Indoles (pharmacology, therapeutic use)
  • Male
  • Meglumine (analogs & derivatives, pharmacology, therapeutic use)
  • Panic Disorder (drug therapy)
  • Rats
  • Rats, Wistar
  • Receptor, Cholecystokinin B
  • Receptors, Cholecystokinin (antagonists & inhibitors, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: